Frida Andersson holds an MSc in Biomedical Science and has strong practical experience in in vivo pharmacology and preclinical model execution.
At Redoxis, Frida contributes to the planning and execution of in vivo studies across a range of inflammation and autoimmune disease models. With expertise in animal handling, dosing techniques, and study coordination, she supports the generation of high-quality and reproducible data for client projects.
Known for her structured approach, reliability, and strong commitment to animal welfare and scientific integrity, Frida is an important member of the Redoxis in vivo team and contributes to the delivery of robust preclinical research.